Effect of variations in treatment regimen and liver cirrhosis on exposure to benzodiazepines during treatment of alcohol withdrawal syndrome
Purpose: Benzodiazepines (BDZs) are the drugs of choice to prevent the symptoms of alcohol withdrawal syndrome (AWS). Various treatment protocols are published and have been shown to be effective in both office-managed and facility-managed treatment of AWS. The aim of this scientific commentary is t...
Saved in:
Main Authors: | Pavel Gershokovich (Author), Kishor M Wasan (Author), Charles Ribeyre (Author), Fady Ibrahim (Author), John H McNeill (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2015-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome
by: Deanna Malone, et al.
Published: (2023) -
Flumazenil in treatment benzodiazepine withdrawal syndrome: Case report
by: Ramah Aleksandar J., et al.
Published: (2015) -
Complex pathogenetic treatment of liver cirrhosis
by: O. F. Dzygal, et al.
Published: (2017) -
Complex pathogenetic treatment of liver cirrhosis
by: O. F. Dzygal, et al.
Published: (2017) -
Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020)